Identification of false-positive QuantiFERON-TB Gold In-Tube assays by repeat testing in HIV-infected patients at low risk for tuberculosis

Clinical Infectious Diseases

Volumn 54, Issue 3, 2012, Pages

  Gray, Jacob ^a   Reves, Randall ^a,b   Johnson, Steven ^a   Belknap, Robert ^a,b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b DENVER HEALTH AND HOSPITAL AUTHORITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULOSTATIC AGENT; VIRUS RNA;

ARTICLE; ASSAY; CD4 LYMPHOCYTE COUNT; FALSE POSITIVE RESULT; GOLD IN TUBE ASSAY; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LATENT TUBERCULOSIS; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCREENING;

ANTI-HIV AGENTS; FALSE POSITIVE REACTIONS; HIV INFECTIONS; HUMANS; REAGENT KITS, DIAGNOSTIC; RETROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS;

EID: 84855870446     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir792     Document Type: Article

References (21)

1. Centers for Disease Control and Prevention (CDC). Decrease in reported tuberculosis cases-United States, 2009. MMWR Morb Mortal Wkly Rep 2010;59:289-94.
2. Centers for Disease Control and Prevention (CDC). Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 2009;58:1-207.
3. Akolo C, Adetifa I, Shepperd S, Volmink J. Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst Rev 2010; (1): CD000171.
4. Centers for Disease Control and Prevention (CDC). Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection-United States, 2010. MMWR Recomm Rep 2010;59:1-25.
5. Mori T, Sakatani M, Yamagishi F, et al. Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med 2004;170:59-64. (Pubitemid 38997752)
6. Bua A, Molicotti P, Delogu G, et al. QuantiFERON TB gold: a new method for latent tuberculosis infection. New Microbiol 2007;30:477-80. (Pubitemid 350183848)
7. Mazurek GH, Zajdowicz MJ, Hankinson AL, et al. Detection of Mycobacterium tuberculosis infection in United States Navy recruits using the tuberculin skin test or whole-blood interferon gamma release assays. Clin Infect Dis 2007;45:826-36. (Pubitemid 47580373)
8. Harada N, Higuchi K, Yoshiyama T, et al. Comparison of the sensitivity and specificity of two whole blood interferon-gamma assays for M. tuberculosis infection. J Infect 2008;56:348-53.
9. Katiyar SK, Sampath A, Bihari S, Mamtani M, Kulkarni H. Use of the QuantiFERON-TB Gold In-Tube test to monitor treatment efficacy in active pulmonary tuberculosis. Int J Tuberc Lung Dis 2008;2:1146-52.
10. Palazzo R, Spensieri F, Massari M, et al. Use of whole-blood samples in in-house bulk and single cell antigen-specific gamma interferon assays for surveillance of Mycobacterium tuberculosis infections. Clin Vaccine Immunol 2008;15:327-37. (Pubitemid 352025523)
11. Aichelburg MC, Rieger A, Breitenecker F, et al. Detection and prediction of active tuberculosis disease by a whole-blood interferongamma release assay in HIV-1-infected individuals. Clin Infect Dis 2009;48:954-62.
12. Raby E, Moyo M, Devendra A, et al. The effects of HIV on the sensitivity of a whole blood IFN-gamma release assay in Zambian adults with active tuberculosis. PLoS One 2008;3:e2489.
13. Aabye MG, Ravn P, PrayGod G, et al. The impact of HIV infection and CD4 cell count on the performance of an interferon gamma release assay in patients with pulmonary tuberculosis. PLoS One 2009;4:e4220.
14. Cattamanchi A, Smith R, Steingart KR, et al. Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systemative review and meta-analysis. J Acquir Immune Defic Syndr 2011;56:230-8.
15. Talati NJ, Seybold U, Humphrey B, et al. Poor concordance between interferon gamma release assays and tuberculin skin tests in diagnosis of latent tuberculosis infection among HIV-infected individuals. BMC Infect Dis 2009;9:15.
16. Luetkemeyer AF, Charlebois ED, Flores LL, et al. Comparison of an interferon-gamma release assay with tuberculin skin testing in HIV-infected individuals. Am J Respir Crit Care Med 2007;175:737-42. Epub 2007 Jan 11. (Pubitemid 46536491)
17. QuantiFERON-TB Gold In-Tube assay [package insert]. Valencia, CA: Cellestis Inc., 2009.
18. Pai M, Joshi R, Dogra S, et al. Serial testing of health care workers for tuberculosis using interferon-gamma assay. Am J Respir Crit Care Med 2006;174:349-55. (Pubitemid 44156616)
19. Yoshiyama T, Harada N, Higuchi K, Nakajima Y, Ogata H. Estimation of incidence of tuberculosis infection in health-care workers using repeated interferon-gamma assays. Epidemiol Infect 2009;137:1691-8.
20. Zwerling A, van den Hof S, Scholten J, Cobelens F, Menzies D, Pai M. Interferon-gamma release assays for tuberculosis screening healthcare workers: a systematic review. Thorax 2011; doi: 10.1136/thx.2010.143180.
21. Schablon A, Harling M, Diel R, Ringshausen FC, Torres Costa J, Nienhaus A. Serial testing with an interferon-c release assay in German healthcare workers. GMS Krankenhhyg Interdiszip 2010;5:Doc5.